• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Edwards Lifesciences

Edwards Lifesciences

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Significant Patient Benefits With Edwards Sapien Valve Demonstrated In 5-Year Partner Trial Data

    Significant Patient Benefits With Edwards Sapien Valve Demonstrated In 5-Year Partner Trial Data

  2. No Surprises in Medtronic's Fiscal Third Quarter

    The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.

  3. Which Funds Own My Stock?

    Ownership data provide a look at who else owns the company.

  4. Home Prices Keep Falling

    The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.